|
1
|
Albores-Saavedra J, Hruban RH, Klimstra DS
and Zamboni G: Invasive adenocarcinoma of the ampullary region.
Bosman FT, Carneiro F, Hruban RH and Theise ND: World health
organization classification of tumours of the digestive system.
IARC Press. (Lyon). 87–91. 2010.
|
|
2
|
Kumari N, Prabha K, Singh RK, Baitha DK
and Krishnani N: Intestinal and pancreatobiliary differentiation in
periampullary carcinoma: The role of immunohistochemistry. Hum
Pathol. 44:2213–2219. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ang DC, Shia J, Tang LH, Katabi N and
Klimstra DS: The utility of immunohistochemistry in subtyping
adenocarcinoma of the ampulla of vater. Am J Surg Pathol.
38:1371–1379. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Carter JT, Grenert JP, Rubenstein L,
Stewart L and Way LW: Tumors of the ampulla of vater:
Histopathologic classification and predictors of survival. J Am
Coll Surg. 207:210–218. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kim WS, Choi DW, Choi SH, Heo JS, You DD
and Lee HG: Clinical significance of pathologic subtype in
curatively resected ampulla of vater cancer. J Surg Oncol.
105:266–272. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Robert PE, Leux C, Ouaissi M, Miguet M,
Paye F, Merdrignac A, Delpero JR, Schwarz L, Carrere N, Muscari F,
et al: Predictors of long-term survival following resection for
ampullary carcinoma: A large retrospective French multicentric
study. Pancreas. 43:692–697. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Nassar H, Albores-Saavedra J and Klimstra
DS: High-grade neuroendocrine carcinoma of the ampulla of vater: A
clinicopathologic and immunohistochemical analysis of 14 cases. Am
J Surg Pathol. 29:588–594. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Carter JT, Grenert JP, Rubenstein L,
Stewart L and Way LW: Neuroendocrine tumors of the ampulla of
Vater: Biological behavior and surgical management. Arch Surg.
144:527–531. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Moncur JT, Lacy BE and Longnecker DS:
Mixed acinar-endocrine carcinoma arising in the ampulla of Vater.
Hum Pathol. 33:449–451. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Musialik JA, Kohut MJ, Marek T, Wodołazski
A and Hartleb M: Composite neuroendocrine and adenomatous carcinoma
of the papilla of Vater. World J Gastroenterol. 15:4199–4200. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhang L and DeMay RM: Cytological features
of mixed adenoneuroendocrine carcinoma of the ampulla: Two case
reports with review of literature. Diagn Cytopathol. 42:1075–1084.
2014. View
Article : Google Scholar : PubMed/NCBI
|
|
12
|
Huang Z, Xiao WD, Li Y, Huang S, Cai J and
Ao J: Mixed adenoneuroendocrine carcinoma of the ampulla: Two case
reports. World J Gastroenterol. 21:2254–2259. 2015.PubMed/NCBI
|
|
13
|
Cordier R: Les cellules argentaffines dans
les tumeurs intestinales. Arch Int Med Exp. 1:59–63. 1924.
|
|
14
|
La Rosa S, Marando A, Sessa F and Capella
C: Mixed adenoneuroendocrine carcinomas (MANECs) of the
gastrointestinal tract: An update. Cancers (Basel). 4:11–30. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Rindi G, Arnold R, Bosman FT, Capella C,
Klimstra DS, Klöppel Komminoth P and Solcia E: Nomenclature and
classification of neuroendocrine neoplasms of the digestive system.
Bosman FT, Carneiro F, Hruban RH and Theise ND: World health
organization classification of tumours of the digestive system.
IARC Press. (Lyon). 13–14. 2010.
|
|
16
|
Khurana A, Sharma A, Gupta G and Gandhi
JS: Peri-ampullary collision tumor-high grade neuroendocrine
carcinoma and signet ring cell carcinoma: A case report and review
of literature. Indian J Pathol Microbiol. 54:161–163. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ginori A, Lo Bello G, Vassallo L and
Tripodi SA: Amphicrine carcinoma of the ampullary region. Tumori.
101:e70–e72. 2015.PubMed/NCBI
|
|
18
|
La Rosa S, Marando A, Furlan D, Sahnane N
and Capella C: Colorectal poorly differentiated neuroendocrine
carcinomas and mixed adenoneuroendocrine carcinomas: Insights into
the diagnostic immunophenotype, assessment of methylation profile
and search for prognostic markers. Am J Surg Pathol. 36:601–611.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Klöppel G, Rindi G, Anlauf M, Perren A and
Komminoth P: Site-specific biology and pathology of
gastroenteropancreatic neuroendocrine tumors. Virchows Arch.
451(Suppl 1): S9–S27. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Harada K, Sato Y, Ikeda H, Maylee H,
Igarashi S, Okamura A, Masuda S and Nakanuma Y: Clinicopathologic
study of mixed adenoneuroendocrine carcinomas of hepatobiliary
organs. Virchows Arch. 460:281–289. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Gurzu S, Kadar Z, Bara T, Bara T Jr,
Tamasi A, Azamfirei L and Jung I: Mixed adenoneuroendocrine
carcinoma of gastrointestinal tract: Report of two cases. World J
Gastroenterol. 21:1329–1333. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
van Krieken JH, Jung A, Kirchner T,
Carneiro F, Seruca R, Bosman FT, Quirke P, Fléjou JF, Plato Hansen
T, de Hertogh G, et al: KRAS mutation testing for predicting
response to anti-EGFR therapy for colorectal carcinoma: Proposal
for an European quality assurance program. Virchows Arch.
453:417–431. 2008. View Article : Google Scholar : PubMed/NCBI
|
